These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 22229758

  • 41. A sequential multiple assignment randomized trial for cocaine cessation and relapse prevention: Tailoring treatment to the individual.
    Schmitz JM, Stotts AL, Vujanovic AA, Weaver MF, Yoon JH, Vincent J, Green CE.
    Contemp Clin Trials; 2018 Feb; 65():109-115. PubMed ID: 29287664
    [Abstract] [Full Text] [Related]

  • 42. A randomized, controlled trial of combined cognitive-behavioral therapy plus prize-based contingency management for cocaine dependence.
    Petitjean SA, Dürsteler-MacFarland KM, Krokar MC, Strasser J, Mueller SE, Degen B, Trombini MV, Vogel M, Walter M, Wiesbeck GA, Farronato NS.
    Drug Alcohol Depend; 2014 Dec 01; 145():94-100. PubMed ID: 25456571
    [Abstract] [Full Text] [Related]

  • 43. Contingent reinforcement of abstinence with individuals abusing cocaine and marijuana.
    Budney AJ, Higgins ST, Delaney DD, Kent L, Bickel WK.
    J Appl Behav Anal; 1991 Dec 01; 24(4):657-65. PubMed ID: 1797769
    [Abstract] [Full Text] [Related]

  • 44. Cocaine abstinence during the "critical period" of a contingency management trial predicts future abstinence in people with cocaine use disorder.
    Regnier SD, Shellenberg TP, Koffarnus MN, Cox DH, Lile JA, Rush CR, Stoops WW.
    Drug Alcohol Depend; 2023 Dec 01; 253():111030. PubMed ID: 38006674
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Contingency management for cocaine treatment: cash vs. vouchers.
    Festinger DS, Dugosh KL, Kirby KC, Seymour BL.
    J Subst Abuse Treat; 2014 Aug 01; 47(2):168-74. PubMed ID: 24746956
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
    Poling J, Oliveto A, Petry N, Sofuoglu M, Gonsai K, Gonzalez G, Martell B, Kosten TR.
    Arch Gen Psychiatry; 2006 Feb 01; 63(2):219-28. PubMed ID: 16461866
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Contingency management is efficacious in opioid-dependent outpatients not maintained on agonist pharmacotherapy.
    Petry NM, Carroll KM.
    Psychol Addict Behav; 2013 Dec 01; 27(4):1036-43. PubMed ID: 23528194
    [Abstract] [Full Text] [Related]

  • 59. Short and long-term improvements in psychiatric symptomatology to validate clinically meaningful treatment outcomes for cocaine use disorders.
    Miguel AQC, Kiluk BD, Babuscio TA, Nich C, Mari JJ, Carroll KM.
    Drug Alcohol Depend; 2019 May 01; 198():126-132. PubMed ID: 30921648
    [Abstract] [Full Text] [Related]

  • 60. Long-term benefits of adding incentives to the community reinforcement approach for cocaine dependence.
    García-Fernández G, Secades-Villa R, García-Rodríguez O, Alvarez-López H, Fernández-Hermida JR, Fernández-Artamendi S, Higgins ST.
    Eur Addict Res; 2011 May 01; 17(3):139-45. PubMed ID: 21447950
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.